Vertex Pharmaceuticals (VRTX) Stock Chart & Stock Price History $446.15 -4.35 (-0.97%) Closing price 06/9/2025 04:00 PM EasternExtended Trading$446.60 +0.45 (+0.10%) As of 08:38 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Vertex Pharmaceuticals Stock Price Performance The Vertex Pharmaceuticals (VRTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 7.68%, with a year-to-date return of 10.79%. In the past month, the stock has increased 4.90%, reflecting recent market activity. As of the latest close, Vertex Pharmaceuticals traded at $446.15 with a market cap of $114.57 billion and volume of 912,384 shares. Five years ago, the stock traded at $274.34, representing a 62.63% increase over that period. At the time, it had a market cap of $71.56 billion and a volume of 1.54 million shares. Receive VRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vertex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.52%1 Month Performance+4.90%3 Month Performance-10.77%Year-To-Date Performance+10.79%1 Year Performance-7.68%5 Year Performance+62.63% VRTX Stock Chart for Tuesday, June, 10, 2025 VRTX Chart by TradingView Vertex Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/09/2025$450.50$446.15-0.97%$451.52$444.84912,384 shs$114.57 billion06/06/2025$443.82$450.50+1.51%$451.66$443.83960,469 shs$115.69 billion06/05/2025$445.85$443.82-0.46%$447.49$437.451.40 million shs$113.97 billion06/04/2025$446.59$445.85-0.17%$453.87$445.84840,145 shs$114.49 billion06/03/2025$445.43$446.59+0.26%$449.85$439.541.68 million shs$114.68 billion06/02/2025$443.01$445.43+0.55%$447.98$439.541.18 million shs$114.39 billion05/30/2025$447.09$443.01-0.91%$447.99$439.372.58 million shs$113.76 billion05/29/2025$445.10$447.09+0.45%$449.22$442.76882,371 shs$114.81 billion05/28/2025$446.00$445.10-0.20%$451.64$443.411.21 million shs$114.30 billion05/27/2025$436.00$446.00+2.29%$447.47$437.342.05 million shs$114.53 billion Get the Latest News and Ratings for VRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vertex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/26/2025$436.00$436.00$436.59$427.431.43 million shs$111.96 billion05/23/2025$434.03$436.00+0.45%$436.59$427.431.43 million shs$111.96 billion05/22/2025$435.32$434.03-0.30%$437.00$429.551.62 million shs$111.46 billion05/21/2025$447.18$435.32-2.65%$445.16$433.771.43 million shs$111.79 billion05/20/2025$440.66$447.18+1.48%$448.00$440.811.51 million shs$114.83 billion05/19/2025$438.65$440.66+0.46%$441.63$435.151.18 million shs$112.64 billion05/16/2025$434.38$438.65+0.98%$438.95$429.941.51 million shs$112.64 billion05/15/2025$421.16$434.38+3.14%$434.42$421.761.94 million shs$111.55 billion05/14/2025$432.00$421.16-2.51%$433.41$416.602.06 million shs$108.15 billion05/13/2025$439.37$432.00-1.68%$442.12$429.542.65 million shs$110.94 billion05/12/2025$425.30$439.37+3.31%$441.10$423.202.10 million shs$112.83 billion05/09/2025$429.60$425.30-1.00%$434.93$424.801.64 million shs$109.34 billion Related Companies Amgen Stock Price Chart Gilead Sciences Stock Price Chart Regeneron Pharmaceuticals Stock Price Chart Alnylam Pharmaceuticals Stock Price Chart Biogen Stock Price Chart United Therapeutics Stock Price Chart Incyte Stock Price Chart Neurocrine Biosciences Stock Price Chart Exelixis Stock Price Chart BioMarin Pharmaceutical Stock Price Chart Receive VRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vertex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRTX) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s Wealth Reset: Could You Be The First Beneficiary?Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsA major regulatory shift is scheduled to take effect this July — and it could have serious implications for yo...Monetary Gold | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Imagine you're driving down I-45 between Dallas and Houston. You come up behind an 18-wheeler, flick your s...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy 2026 will be a disaster for many Americans2025 Market Crash The first-quarter stock crash left investors wondering what lies ahead. Today 50-year Wal...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
